Teva Pharmaceutical Industries Ltd TEVA
3 trading plans running, 45 Form 144 notices for $127.3M
10-Q, 10-K and Form 144What TEVA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 4, 2026 to Jun 5, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Dr. Eric Hughes EVP, Global R&D and Chief Medical Officer |
Adopted 10b5-1 plan | Sep 1, 2026 | 10-Q Nov 3, 2026 |
| Christine Fox EVP, U.S. Commercial |
Adopted 10b5-1 plan | Aug 4, 2026 | 10-Q Nov 3, 2026 |
| Matthew Shields EVP, Teva Global Operations |
Adopted 10b5-1 plan | Aug 4, 2026 | 10-Q Nov 3, 2026 |
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 12, 2026 | Sabag Mark Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL |
44,710 | $2.0M |
| Nov 12, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
20,003 | $856K |
| Nov 10, 2026 | Francis Richard D. Officer |
250,000 | $10.7M |
| Nov 9, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
25,000 | $1.1M |
| Nov 5, 2026 | Sabag Mark Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL |
46,000 | $1.9M |
| Nov 4, 2026 | Bergwerk Dov Senior VP General Counsel Corporate Secretary |
26,260 | $1.1M |
| Sep 21, 2026 | Savage Brian Officer, CHIEF LEGAL OFFICER |
7,028 | $273K |
| Sep 18, 2026 | Bridger Management, LLC (1) Shareholder |
367,600 | $14.4M |
| Aug 17, 2026 | Lippman Evan Officer, EVP BUSINESS DEVELOPMENT |
18,600 | $680K |
| Aug 3, 2026 | Hughes Eric A Executive VP Global R&D and Chief Med Officer |
25,578 | $892K |
| Aug 3, 2026 | Jover Placid Executive VP, Chief HR Officer |
12,827 | $447K |
| Jun 18, 2026 | Shields Matthew Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS |
9,989 | $322K |
| Jun 11, 2026 | Kalif Eliyahu Sharon Officer, EVP CHIEF FINANCIAL OFFICER |
106,563 | $3.6M |
| Jun 5, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
6,153 | $211K |
| Jun 3, 2026 | Shields Matthew Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS |
16,195 | $532K |
| May 14, 2026 | Lippman Evan Officer, EXECUTIVE VP BUSINESS DEVELOPMENT |
41,658 | $1.5M |
| May 14, 2026 | Kalif Eliyahu Sharon Officer, EVP CHIEF FINANCIAL OFFICER |
153,251 | $5.5M |
| May 5, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
30,000 | $1.1M |
| May 4, 2026 | Sabag Mark Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL |
144,180 | $5.0M |
| Apr 30, 2026 | Christine Fox Officer |
21,258 | $751K |
| Mar 17, 2026 | Sabag Mark Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL |
62,102 | $1.9M |
| Mar 5, 2026 | Shields Matthew Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS |
17,295 | $548K |
| Mar 5, 2026 | Jover Placid Officer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER |
14,150 | $448K |
| Mar 5, 2026 | Savage Brian Officer, INTERIM CHIEF LEGAL OFFICER |
1,127 | $36K |
| Mar 5, 2026 | Fox Christine Officer, EVP HEAD OF US COMMERCIAL |
7,924 | $251K |
| Mar 5, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
20,025 | $634K |
| Mar 5, 2026 | Hughes Eric A Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER |
9,533 | $302K |
| Mar 5, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
17,295 | $548K |
| Mar 4, 2026 | Fox Christine Officer, EVP HEAD OF US COMMERCIAL |
9,908 | $322K |
| Mar 4, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
23,393 | $759K |
| Mar 4, 2026 | Hughes Eric A Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER |
11,277 | $366K |
| Mar 4, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
91,345 | $3.0M |
| Mar 3, 2026 | Savage Brian Officer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER |
1,274 | $41K |
| Mar 3, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
442,935 | $14.3M |
| Mar 3, 2026 | Hughes Eric A Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER |
80,762 | $2.6M |
| Mar 3, 2026 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
128,985 | $4.2M |
| Feb 26, 2026 | Kalif Eliyahu Sharon Officer, EVP CHIEF FINANCIAL OFFICER |
345,810 | $11.6M |
| Feb 18, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
447,778 | $15.3M |
| Feb 18, 2026 | Francis Richard D Officer, PRESIDENT AND CEO |
447,778 | $448K |
| Dec 12, 2025 | Bridger Management, LLC (1) Shareholder |
150,000 | $4.5M |
| Dec 9, 2025 | Sabag Mark Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL |
216,892 | $6.2M |
| Dec 9, 2025 | Daniell Richard Officer, EXECUTIVE VP EUROPEAN COMMERCIAL |
115,468 | $3.3M |
| Nov 26, 2025 | Bridger Management, LLC (1) Shareholder |
50,000 | $1.2M |
| Nov 20, 2025 | Fox Christine Officer, EVP HEAD OF US COMMERCIAL |
28,229 | $700K |
| Nov 14, 2025 | Fox Christine Officer, EVP HEAD OF US COMMERCIAL |
30,000 | $753K |
Show the other 37 notices
From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.